retatrutide clinical trial weight loss data 💉 may be redefining obesity treatment. New from TRIUMPH-1 showed: 🔥 ~28% average over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Percent of participants achieving liver

Eli Lilly and Company

Without these supporting behaviors, a patient will likely regain weight when they reduce dosage or stop taking the drug

Easy from Start to Finish Select a Treatment Browse our treatment categories and choose what's right for you

Eliminating the need for frequent in-person visits with telehealth promotes greater consistency and makes it easier to stay accountable.Telehealth has transformed the delivery What Hormone Optimization Can Do For You Hormone optimization is a powerful tool that supports overall health by helping the body maintain balance, energy, and efficient metabolic function

Blood pressure reductions observed in clinical trials, averaging nearly 10 mm Hg systolic and 4 mm Hg diastolic, translate to meaningful cardiovascular risk reduction

Molecule of the Month: GLP-1 Receptor Agonists Popular and effective drugs for the treatment of obesity and diabetes Improving on a lizard toxin Small molecule mimics Exploring the Structure Compare how peptide-based and small molecule drugs bind to the GLP-1 receptor While peptide-based GLP-1 receptor agonists all bind to the GLP-1 receptor in similar ways, the small molecule orforglipron is much smaller with far fewer interactions